Study unveils GRK2 as therapeutic target in Sjögren’s syndrome
Aug. 22, 2024
G protein-coupled receptor kinase 2 (GRK2) is a crucial kinase that has been shown to interact with multiple signaling molecules under different pathological conditions, including fibrosis.